Fierce Pharma

MAY 31, 2023

FDA warns patients about compounded versions of Novo Nordisk's Ozempic, Wegovy kdunleavy Wed, 05/31/2023 - 13:02

Compounding 138

Compounding FDA 138

PhRMA

JUNE 2, 2023

With Congress discussing policy changes that would lower drug costs for patients and rein in powerful middlemen, insurers and their PBMs are dusting off their old playbook and once again threatening to increase costs for employers if required to do their job and actually provide meaningful coverage to patients. But recent remarks by one executive make clear that the PBM industry has a choice: protect its profits or lower costs for patients.

Insurance 306

Insurance 306

Drug Topics

JUNE 2, 2023

New research suggests that chronotropic incompetence contributes to exercise limitations in Long COVID.

187

187

Pharmacy Times

JUNE 2, 2023

Investigators found thinner ventricular walls, disorganized and ruptured myocardial fiber, mild inflammatory infiltration, and mild epicardia or interstitial fibrosis in the hearts of mice infected with COVID-19.

181

181

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

IDStewardship

JUNE 1, 2023

In this article the adoption of Firstline as a city-wide platform to support antimicrobial stewardship in collaboration with New York City Department of Health and Mental Hygiene is discussed. Interview with: William Greendyke, M.D. Interview by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted 3 June 2023 We have come a long way since the term “ Antimicrobial Stewardship ” first appeared in the medical literature in 1996, brought to us by John McGowan and Dale Gerding.

Hospitals 147

Hospitals Nursing Homes Communication Medical Schools 147

PhRMA

MAY 30, 2023

As we recognize Mental Health Awareness Month, I had the opportunity to connect with PhRMA board member Barry Greene, CEO of Sage Therapeutics, about the company’s efforts to address mental health.

258

258

Pharmacy Times

JUNE 1, 2023

Pharmacogenomic testing in combination with therapeutic drug monitoring can be a cost effective and efficient way to advance psychiatric drug therapy.

149

149

Fierce Healthcare

JUNE 2, 2023

Pharma giant Bayer is launching a precision health unit as it ramps up its investment in consumer-facing digital health tools. | Pharma giant Bayer is launching a precision health unit as it ramps up its investment in consumer-facing digital health tools.

145

145

STAT

JUNE 1, 2023

In a bold move, Coherus BioSciences plans to sell a biosimilar version of Humira — one of the world’s best-selling medicines — at a steep discount, and will work with Mark Cuban’s generic drug company to make the medicine available directly to consumers for even less. Specifically, the Coherus medicine will carry a $995 list price for a carton of two autoinjectors, an 85% discount from the $6,922 that AbbVie charges for Humira, which is used to treat rheumatoid arthri

Pharmaceutical Companies 145

Pharmaceutical Companies Pharmaceutical Companies 145

Drug Topics

JUNE 1, 2023

Abrysvo is the second RSV vaccine approved by the FDA.

Vaccines 187

Vaccines FDA 187

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

JUNE 1, 2023

Pfizer Inc’s bivalent respiratory syncytial virus (RSV) vaccine Abrysvo is indicated to prevent lower respiratory tract disease caused by RSV in individuals 60 years of age and older.

Vaccines 139

Vaccines FDA 139

Fierce Healthcare

JUNE 1, 2023

The Centers for Medicare and Medicaid Services outlined plans Thursday to broadly cover a new class of Alzheimer’s drugs once the medications get full approval from the Food and Drug Administration | CMS outlined plans Thursday to broadly cover a new class of Alzheimer’s drugs once the medications get full approval from the Food and Drug Administration.

FDA 145

FDA 145

Fierce Pharma

MAY 31, 2023

Adding Kisqali to endocrine therapy after surgery reduced the risk of invasive tumor recurrence or death by 25% in certain early-stage breast cancers.

132

132

Drug Topics

MAY 30, 2023

Part of the risk of developing kidney involvement begins when type 1 diabetes mellitus (T1DM) sets in and establishes itself in the patient, with up to 65% of children experiencing acute kidney injury during T1DM onset, which can further predispose to the development of future chronic kidney disease.

187

187

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

MAY 30, 2023

Individuals administered oral semaglutide 50 mg achieved a statistically significant weight loss of approximately 17.4% after 68 weeks, according to Novo Nordisk.

132

132

Fierce Healthcare

JUNE 1, 2023

A pair of new healthcare workforce surveys outline widespread reports of discrimination, racism and workplace violence perpetuated by patients and coworkers alike. | A pair of polls released this week detail the interpersonal difficulties nurses and other healthcare workers face in the workplace.

134

134

STAT

JUNE 1, 2023

Tempus, a company that combines DNA sequencing for cancer with artificial intelligence, said Thursday that it is launching a voice-and-text assistant called Tempus One that will give physicians much easier access to patient data. The AI assistant is being launched ahead of the annual meeting of the American Society of Clinical Oncology in Chicago. Eric Lefkofsky, Tempus’ founder and CEO, told STAT Tempus will be rolling the product, called Tempus One, out to the 6,000 doctors that prescri

128

128

Drug Topics

MAY 31, 2023

The frequency of drug manufacturer coupon utilization is associated with more market competition—but not patients’ out-of-pocket costs.

187

187

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

MAY 31, 2023

As more becomes known about Crohn disease, treatment modalities have evolved with biologic monoclonal antibodies becoming a key part of guideline- and evidence-based medicine.

132

132

Fierce Healthcare

MAY 30, 2023

Denials of health insurance claims are rising—and getting weirder pminemyer Tue, 05/30/2023 - 10:51

Insurance 132

Insurance 132

Fierce Pharma

JUNE 1, 2023

After a panel of independent experts endorsed a narrow approval for AstraZeneca and Merck’s Lynparza in metastatic castration-resistant prostate cancer (mCRPC), the FDA has followed suit. | The drug is now approved to treat BRCA-mutated metastatic castration-resistant prostate cancer in combination with Johnson & Johnson’s Zytiga and a corticosteroid.

FDA 128

FDA 128

Drug Topics

JUNE 2, 2023

Yusimry (adalimumab-aqvh) is 1 of 9 FDA-approved adalimumab biosimilars and is a low-concentration, citrate-free product.

FDA 185

FDA 185

Pharmacy Times

MAY 29, 2023

Cases address gastrointestinal issues and alcohol abuse.

131

131

Fierce Healthcare

MAY 30, 2023

Long COVID described as a 'syndrome of syndromes' in NIH funded research fdiamond Tue, 05/30/2023 - 12:16

131

131

Fierce Pharma

MAY 30, 2023

Alnylam sticks with aggressive litigation strategy against Pfizer and Moderna, filing yet another patent lawsuit zbecker Tue, 05/30/2023 - 10:24

122

122

Drug Topics

MAY 30, 2023

Quality of life (QOL) for people living with autoimmune diseases benefits from an integrated approach that considers individual immune system sensitivities and patients’ life circumstances, a new study shows.

Immunization 184

Immunization 184

Pharmacy Times

JUNE 1, 2023

Investigators previously reported a statistically significant improvement in radiographic progression-free survival in the full intention-to-treat population of adults with deleterious or suspected deleterious BRCA-mutated metastatic castration-resistant prostate cancer.

FDA 123

FDA 123

Fierce Healthcare

JUNE 1, 2023

Less than a month after CVS Health acquired Oak Street Health, the primary care provider plans to expand into four more states. | The company plans to open value-based primary care centers in Little Rock, Arkansas; Des Moines and Davenport, Iowa; Kansas City, Kansas and Richmond, Virginia, beginning this summer. Oak Street Health will operate centers in 25 states by the end of the year.

127

127

Fierce Pharma

MAY 30, 2023

After price cuts, Eli Lilly inks $13.

122

122

Drug Topics

MAY 31, 2023

Pharmapod’s Incident Management reporting platform + Patient Safety Organization improves processes to enhance medication and patient safety

184

184

Pharmacy Times

JUNE 1, 2023

The 2023 ASCO Annual Meeting is being held in Chicago, Illinois from June 2 to 6.

123

123

Fierce Healthcare

MAY 30, 2023

UnitedHealthcare, docs still at odds over prior authorization policy for colonoscopies fdiamond Tue, 05/30/2023 - 17:17

124

124

Fierce Pharma

JUNE 2, 2023

Lynparza may be the most popular PARP inhibitor, but a use restriction in ovarian cancer has been a thorn in AstraZeneca’s side. | AstraZeneca is bringing on Imfinzi to potentially help Lynparza reach a broader ovarian cancer population. But the lack of evidence for contribution from Imfinzi and a regulatory concern over the use of PARP inhibitors outside BRCA-mutant tumors could make it hard for AstraZeneca to win over the FDA.

FDA 119

FDA 119